|
1
|
de Thé H, Chomienne C, Lanotte M, Degos L
and Dejean A: The t(15;17) translocation of acute promyelocytic
leukaemia fuses the retinoic acid receptor alpha gene to a novel
transcribed locus. Nature. 347:558–561. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Goddard AD, Borrow J, Freemont PS and
Solomon E: Characterization of a zinc finger gene disrupted by the
t(15;17) in acute promyelocytic leukemia. Science. 254:1371–1374.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tong JH, Dong S, Geng JP, Huang W, Wang
ZY, Sun GL, Chen SJ, Chen Z, Larsen CJ and Berger R: Molecular
rearrangements of the MYL gene in acute promyelocytic leukemia
(APL, M3) define a breakpoint cluster region as well as some
molecular variants. Oncogene. 7:311–316. 1992.PubMed/NCBI
|
|
4
|
Fujisawa S, Ohno R, Shigeno K, Sahara N,
Nakamura S, Naito K, Kobayashi M, Shinjo K, Takeshita A, Suzuki Y,
et al: Pharmacokinetics of arsenic species in Japanese patients
with relapsed or refractory acute promyelocytic leukemia treated
with arsenic trioxide. Cancer Chemother Pharmacol. 59:485–493.
2007. View Article : Google Scholar
|
|
5
|
Kiguchi T, Yoshino Y, Yuan B, Yoshizawa S,
Kitahara T, Akahane D, Gotoh M, Kaise T, Toyoda H and Ohyashiki K:
Speciation of arsenic trioxide penetrates into cerebrospinal fluid
in patients with acute promyelocytic leukemia. Leuk Res.
34:403–405. 2010. View Article : Google Scholar
|
|
6
|
Shen Zx, Chen GQ, Ni JH, Li XS, Xiong SM,
Qiu QY, Zhu J, Tang W, Sun GL, Yang KQ, et al: Use of arsenic
trioxide (As2O3) in the treatment of acute
promyelocytic leukemia (APL): II. Clinical efficacy and
pharmacokinetics in relapsed patients. Blood. 89:3354–3360.
1997.PubMed/NCBI
|
|
7
|
Yoshino Y, Yuan B, Miyashita SI, Iriyama
N, Horikoshi A, Shikino O, Toyoda H and Kaise T: Speciation of
arsenic trioxide metabolites in blood cells and plasma of a patient
with acute promyelocytic leukemia. Anal Bioanal Chem. 393:689–697.
2009. View Article : Google Scholar
|
|
8
|
Iriyama N, Yoshino Y, Yuan B, Horikoshi A,
Hirabayashi Y, Hatta Y, Toyoda H and Takeuchi J: Speciation of
arsenic trioxide metabolites in peripheral blood and bone marrow
from an acute promyelocytic leukemia patient. J Hematol Oncol.
5:12012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yuan B, Yoshino Y, Kaise T and Toyoda H:
Application of arsenic trioxide therapy for patients with leukemia.
Biological Chemistry of Arsenic, Antimony and Bismuth. Sun H: John
Wiley and Sons, Ltd; Chichester: pp. 263–292. 2011
|
|
10
|
Soignet SL, Maslak P, Wang ZG, Jhanwar S,
Calleja E, Dardashti LJ, Corso D, DeBlasio A, Gabrilove J,
Scheinberg DA, et al: Complete remission after treatment of acute
promyelocytic leukemia with arsenic trioxide. N Engl J Med.
339:1341–1348. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Surh YJ: Cancer chemoprevention with
dietary phytochemicals. Nat Rev Cancer. 3:768–780. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ramos AM and Aller P: Quercetin decreases
intracellular GSH content and potentiates the apoptotic action of
the antileukemic drug arsenic trioxide in human leukemia cell
lines. Biochem Pharmacol. 75:1912–1923. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sánchez Y, Amrán D, Fernández C, de Blas E
and Aller P: Genistein selectively potentiates arsenic
trioxide-induced apoptosis in human leukemia cells via reactive
oxygen species generation and activation of reactive oxygen
species-inducible protein kinases (p38-MAPk, AMPK). Int J Cancer.
123:1205–1214. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hou DX, Fujii M, Terahara N and Yoshimoto
M: Molecular mechanisms behind the chemopreventive effects of
anthocyanidins. J Biomed Biotechnol. 2004:321–325. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hafeez BB, Siddiqui IA, Asim M, Malik A,
Afaq F, Adhami VM, Saleem M, Din M and Mukhtar H: A dietary
anthocyanidin delphinidin induces apoptosis of human prostate
cancer PC3 cells in vitro and in vivo: Involvement of nuclear
factor-kappaB signaling. Cancer Res. 68:8564–8572. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Afaq F, Zaman N, Khan N, Syed DN, Sarfaraz
S, Zaid MA and Mukhtar H: Inhibition of epidermal growth factor
receptor signaling pathway by delphinidin, an anthocyanidin in
pigmented fruits and vegetables. Int J Cancer. 123:1508–1515. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yun JM, Afaq F, Khan N and Mukhtar H:
Delphinidin, an anthocyanidin in pigmented fruits and vegetables,
induces apoptosis and cell cycle arrest in human colon cancer
HCT116 cells. Mol Carcinog. 48:260–270. 2009. View Article : Google Scholar
|
|
18
|
Lazzè MC, Savio M, Pizzala R, Cazzalini O,
Perucca P, Scovassi AI, Stivala LA and Bianchi L: Anthocyanins
induce cell cycle perturbations and apoptosis in different human
cell lines. Carcinogenesis. 25:1427–1433. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cvorovic J, Tramer F, Granzotto M,
Candussio L, Decorti G and Passamonti S: Oxidative stress-based
cytotoxicity of delphinidin and cyanidin in colon cancer cells.
Arch Biochem Biophys. 501:151–157. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Suzuki R, Tanaka M, Takanashi M, Hussain
A, Yuan B, Toyoda H and Kuroda M: Anthocyanidins-enriched bilberry
extracts inhibit 3T3-L1 adipocyte differentiation via the insulin
pathway. Nutr Metab (Lond). 8:142011. View Article : Google Scholar
|
|
21
|
Kausar H, Jeyabalan J, Aqil F, Chabba D,
Sidana J, Singh IP and Gupta RC: Berry anthocyanidins
synergistically suppress growth and invasive potential of human
non-small-cell lung cancer cells. Cancer Lett. 325:54–62. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Aiyer HS, Warri AM, Woode DR,
Hilakivi-Clarke L and Clarke R: Influence of berry polyphenols on
receptor signaling and cell-death pathways: Implications for breast
cancer prevention. J Agric Food Chem. 60:5693–5708. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hou DX, Ose T, Lin S, Harazoro K, Imamura
I, Kubo M, Uto T, Terahara N, Yoshimoto M and Fujii M:
Anthocyanidins induce apoptosis in human promyelocytic leukemia
cells: Structure-activity relationship and mechanisms involved. Int
J Oncol. 23:705–712. 2003.PubMed/NCBI
|
|
24
|
Katsube N, Iwashita K, Tsushida T, Yamaki
K and Kobori M: Induction of apoptosis in cancer cells by Bilberry
(Vaccinium myrtillus) and the anthocyanins. J Agricultural and Food
Chem. 51:68–75. 2003. View Article : Google Scholar
|
|
25
|
Hou DX, Tong X, Terahara N, Luo D and
Fujii M: Delphinidin 3-sambubioside, a Hibiscus anthocyanin,
induces apoptosis in human leukemia cells through reactive oxygen
species-mediated mitochondrial pathway. Arch Biochem Biophys.
440:101–109. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kon A, Yuan B, Hanazawa T, Kikuchi H, Sato
M, Furutani R, Takagi N and Toyoda H: Contribution of membrane
progesterone receptor α to the induction of progesterone-mediated
apoptosis associated with mitochondrial membrane disruption and
caspase cascade activation in Jurkat cell lines. Oncol Rep.
30:1965–1970. 2013.PubMed/NCBI
|
|
27
|
Yoshino Y, Yuan B, Kaise T, Takeichi M,
Tanaka S, Hirano T, Kroetz DL and Toyoda H: Contribution of
aquaporin 9 and multidrug resistance-associated protein 2 to
differential sensitivity to arsenite between primary cultured
chorion and amnion cells prepared from human fetal membranes.
Toxicol Appl Pharmacol. 257:198–208. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yuan B, Ohyama K, Bessho T and Toyoda H:
Contribution of inducible nitric oxide synthase and
cyclooxygenase-2 to apoptosis induction in smooth chorion
trophoblast cells of human fetal membrane tissues. Biochem Biophys
Res Commun. 341:822–827. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Imai M, Yuan B, Kikuchi H, Saito M, Ohyama
K, Hirobe C, T Oshima T, Hosoya T, Morita H and Toyoda H: Growth
inhibition of a human colon carcinoma cell, COLO 201, by a natural
product, Vitex agnus-castus fruits extract, in vivo and in vitro.
Adv Biol Chem. 2:20–28. 2012. View Article : Google Scholar
|
|
30
|
Iriyama N, Yuan B, Yoshino Y, Hatta Y,
Horikoshi A, Aizawa S, Takeuchi J and Toyoda H: Aquaporin 9, a
promising predictor for the cytocidal effects of arsenic trioxide
in acute promyelocytic leukemia cell lines and primary blasts.
Oncol Rep. 29:2362–2368. 2013.PubMed/NCBI
|
|
31
|
Wang ZY and Chen Z: Acute promyelocytic
leukemia: From highly fatal to highly curable. Blood.
111:2505–2515. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Bremer E, van Dam G, Kroesen BJ, de Leij L
and Helfrich W: Targeted induction of apoptosis for cancer therapy:
Current progress and prospects. Trends Mol Med. 12:382–393. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ryter SW, Kim HP, Hoetzel A, Park JW,
Nakahira K, Wang X and Choi AM: Mechanisms of cell death in
oxidative stress. Antioxid Redox Signal. 9:49–89. 2007. View Article : Google Scholar
|
|
34
|
Kantari C and Walczak H: Caspase-8 and
bid: Caught in the act between death receptors and mitochondria.
Biochim Biophys Acta. 1813:558–563. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li H, Zhu H, Xu CJ and Yuan J: Cleavage of
BID by caspase 8 mediates the mitochondrial damage in the Fas
pathway of apoptosis. Cell. 94:491–501. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Luo X, Budihardjo I, Zou H, Slaughter C
and Wang X: Bid, a Bcl2 interacting protein, mediates cytochrome c
release from mitochondria in response to activation of cell surface
death receptors. Cell. 94:481–490. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Castro AF and Altenberg GA: Inhibition of
drug transport by genistein in multidrug-resistant cells expressing
P-glycoprotein. Biochem Pharmacol. 53:89–93. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Kitagawa S: Inhibitory effects of
polyphenols on P-glycoprotein-mediated transport. Biol Pharm Bull.
29:1–6. 2006. View Article : Google Scholar : PubMed/NCBI
|
